Wang K, Jiang H, Li W, Qiang M, Dong T, Li H
However, with few clinical trials, it requires consistent, long-term use to achieve and sustain results
Conducted between June 2011 and March 2013 at 191 sites in 27 countries in Europe, North America, South America, Asia, and Australia this was a randomised, placebo-controlled trial designed to evaluate the efficacy and safety of 3mg liraglutide 'injected subcutaneously once daily, as an adjunct to a reduced-calorie diet and increased physical activity, for weight management in overweight or obese adults who did not have diabetes at baseline.' A total of 3,731 individuals participated in the trial, of whom 2,487 were assigned to lifestyle intervention plus liraglutide and 1,244 to lifestyle intervention with a placebo
Active Brightening Phase Progressive reduction in melanin synthesis becomes visible at the skin surface as pigmented cells shed through natural turnover